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protein complex different from   -secretase. We found that 
during zebrafish embryogenesis this complex is involved in 
the patterning of the axial mesendoderm, a process con-
trolled by the Nodal signaling pathway. 
 Copyright © 2006 S. Karger AG, Basel 
 Introduction 
 Intramembrane proteolysis is an only recently identi-
fied mechanism underlying various important cellular 
processes such as cholesterol homeostasis, ER stress, cell 
fate decisions, signal peptide cleavage, and removal of 
transmembrane domain (TMD) stubs  [1] . An extensively 
studied example of intramembrane proteolysis is the   -
secretase-mediated cleavage of the   -amyloid precursor 
protein (APP), a critical step in the development of Alz-
heimer’s disease (AD)  [2] . Upon initial ectodomain shed-
ding by   - or   -secretase, the remaining APP C-terminal 
fragment is cleaved within its TMD by   -secretase, a 
membrane protein complex of high molecular weight 
with an unusual aspartyl protease activity. The consecu-
tive cleavage of APP by   - and   -secretase results in the 
generation of small peptides, including the 40- to 42-
amino acid amyloid-  peptide (A  ), which are released 
into the extracellular space  [2] . The neurotoxic, highly 
amyloidogenic 42-amino acid A  variant is believed to
 Key Words 
 Nodal modulator   Presenilin   Signal peptide peptidase   
Nodal signaling pathway   Nicastrin-like protein  
 Abstract 
 Amyloid-  peptide (A  ) is generated by   -secretase, a mem-
brane protein complex with an unusual aspartyl protease ac-
tivity consisting of the four components presenilin, nicastrin, 
APH-1 and PEN-2. Presenilin is considered the catalytic sub-
unit of this complex since it represents the prototype of the 
new family of intramembrane-cleaving GxGD-type aspartyl 
proteases. Recently, five novel members of this family and a 
nicastrin-like protein were identified. Whereas one of the 
GxGD-type proteins was shown to be identical with signal 
peptide peptidase (SPP), the function of the others, now 
called SPP-like proteins (SPPLs), is not known. We therefore 
analyzed SPPL2b and SPPL3 and demonstrated that they lo-
calize to different subcellular compartments suggesting 
nonredundant functions. This was supported by different 
phenotypes obtained in knockdown studies in zebrafish 
embryos. In addition, these phenotypes could be pheno-
copied by ectopic expression of putative active site mutants, 
providing strong evidence for a proteolytic function of 
SPPL2b and SPPL3. We also identified and characterized the 
nicastrin-like protein nicalin which, together with the 130-
kDa protein NOMO (Nodal modulator), forms a membrane 
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be the pathological agent that initiates AD. The physio-
logical role of the APP processing is not known, but   -
secretase-mediated cleavage of other substrates, most im-
portantly the Notch receptor, is required during develop-
ment and maintenance of multicellular organisms  [3] . 
 Four   -secretase complex components have been iden-
tified: presenilin, nicastrin, APH-1 and PEN-2  [4] . Their 
simultaneous expression in yeast, an organism that lacks 
any endogenous   -secretase activity, results in the recon-
stitution of   -secretase complex formation and activity, 
demonstrating that these four membrane proteins are the 
core components of the complex  [5] .   -Secretase activity 
depends on the presence of two conserved aspartate resi-
dues in either presenilin 1 or presenilin 2, two polytopic 
membrane proteins with partially redundant function 
 [4] . Presenilins constitutively undergo endoproteolysis, 
leading to the generation of N- and C-terminal fragments 
which remain bound to each other and apparently con-
stitute the catalytic site of the   -secretase. The active site 
aspartate residues of the presenilins reside within their 
TMDs 6 and 7, in agreement with an intramembrane 
cleavage mechanism. The TMD 7 aspartate is located 
within the highly conserved sequence motif GxGD  [6] , 
which is also found in other intramembrane cleaving 
proteases, the bacterial type 4 prepilin peptidases and 
signal peptide peptidase (SPP) (see below). These and 
other data strongly suggest that the presenilins are the 
proteolytically active components of the   -secretase com-
plex. In contrast, the role of the other three subunits is 
less well understood. The type I glycoprotein nicastrin 
(see below) and the polytopic membrane protein APH-1 
might form a precomplex to which first presenilin holo-
protein is added  [7] . The subsequent addition of PEN-2 
facilitates presenilin endoproteolysis leading to the gen-
eration of the active complex. For a detailed description 
of   -secretase assembly and function see the paper by
Kaether et al. [this issue, pp. 275–283].
 SPP-Like Proteins 
 SPP and SPP-like proteins (SPPLs) were originally 
identified as presenilin homologues (PSHs) in a database 
search  [8] . Five PSH genes were described and shown to 
encode polytopic membrane proteins with a predicted to-
pology similar, but inverted to that of presenilins ( fig. 1 a). 
Moreover, their sequences contained two conserved as-
partate residues within putative TMDs and a highly con-
served PALLYL motif reminiscent of the presenilin PALP 
sequence, suggesting the existence of a family of unusual 
aspartyl proteases with the sequence GxGD as a signature 
motif  [9] . This hypothesis was confirmed by the finding 
that one of the PSHs is identical to SPP  [10] , a protease 
cleaving the hydrophobic signal peptides after their re-
moval from newly synthesized secreted or membrane 
proteins by signal peptidase. Mutation of the aspartate 
within the GxGD motif of SPP abolished this activity, 
supporting the idea that SPP is indeed an aspartyl prote-
ase. Subsequently,   -secretase inhibitors were shown to 
also block SPP activity, suggesting a common cleavage 
mechanism of   -secretase and SPP  [11] . In addition, the 
liberation of signal peptides by signal peptidase, a step 
analogous to the ectodomain shedding of   -secretase 
substrates, was shown to be required for intramembrane 
processing, indicating that SPP and   -secretase use a 
similar substrate recognition mechanism  [12] . Thus, the 
discrimination of SPP and   -secretase substrates appears 
to be primarily based on their membrane orientation:   -
secretase cleaves only type I substrates, SPP accepts only 
type II substrates, in agreement with the inverted mem-
brane orientation of their active site-forming TMDs  [13] . 
However, SPP differs from presenilin in that it does not 
undergo endoproteolysis and that it does not need a high-
molecular-weight complex for activity. Although SPP di-
merization has been shown to occur  [13–15] , its biologi-
cal relevance is not clear.
 One of the physiological functions of signal peptide 
processing in mammalian cells is the generation of frag-
ments from MHC class I molecules which serve as human 
lymphocyte antigen E epitopes to report the immuno-
competence of antigen-presenting cells  [16] . In  Caeno-
rhabditis elegans , SPP has been shown to be required for 
embryonic development and suggested to be involved in 
the lipoprotein receptor pathway  [17] . In contrast, noth-
ing is known about the function of the other four PSHs, 
now known as SPPLs. Based on their sequence homology 
to SPP  [8] and their membrane topology  [13] , they might 
represent intramembrane cleaving aspartyl proteases as 
well, but no substrates have been identified so far. Two of 
the four human SPPLs, SPPL2b and SPPL3, are conserved 
in all vertebrates, including the zebrafish, and were cho-
sen for a biochemical and functional study  [15] . Analysis 
of their subcellular localization in cultured human em-
bryonic kidney HEK293 cells by immunofluorescence 
microscopy revealed that SPPL3, like SPP, localizes to the 
endoplasmic reticulum, whereas SPPL2b is predomi-
nantly found in endocytic/lysosomal compartments 
( fig. 1 b). This suggested that at least one of the SPPLs 
might have a function different from SPP. To examine 
this further, we studied the role of SPP, SPPL2b and SPPL3 
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during zebrafish embryonic development  [15] . The cor-
responding zebrafish genes,  spp ,  sppl2 and  sppl3 are high-
ly homologous to their human counterparts and ex-
pressed throughout early embryogenesis. Knockdown of 
each of these genes using antisense oligonucleotides re-
sulted in embryonic lethal phenotypes demonstrating an 
essential role in zebrafish development. Whereas injec-
tion of  spp and  sppl3 -specific oligonucleotides led to a 
neuronal degeneration phenotype due to enhanced cell 
death, knockdown of  sppl2b resulted in the development 
of an abnormal caudal vein  [15] . Importantly, we ob-
tained identical phenotypes by injecting mRNAs encod-
ing SPP or SPPL proteins harboring a mutation of the 
aspartate residue within the GxGD motif. This mutation 
has already been shown to act as dominant-negative mu-
tation in human SPP  [10] . We, therefore, concluded that 
SPPLs most likely represent aspartyl proteases with non-
redundant functions.
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 Fig. 1.  a Presenilins and SPP/SPPLs have opposite membrane to-
pology. Both are believed to contain nine TMDs with the prese-
nilins’ N-termini in the cytosol and the SPP/SPPLs’ N-termini in 
the lumen (SPPL2a, b, c also contain a signal peptide which is not 
shown here). In contrast to SPP/SPPLs, presenilins are endopro-
teolyzed within the large cytoplasmic loop during   -secretase 
complex formation.  b SPPL2b localizes to endosomal/lysosomal 
compartments. Immunofluorescent microscopy of HEK293 cells 
shows a high degree of colocalization of SPPL2b with LAMP-2, a 
marker for lysosomes, and only little colocalization with BiP, an 
endoplasmic reticulum-resident protein. 
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 Nicalin (Nicastrin-Like Protein) 
 The type I transmembrane protein nicastrin was orig-
inally identified as presenilin-binding factor that affects 
APP processing  [18] as well as Notch signaling in  C. ele-
gans  [18, 19] . It was subsequently shown to represent an 
obligate component of the   -secretase complex  [20] and 
to be required for the reconstitution of   -secretase activ-
ity  [5] . Its extracytosolic domain contains N-linked car-
bohydrates which undergo maturation during passage 
through the secretory pathway  [20, 21] . This maturation, 
together with a conformational change leading to trypsin 
resistance  [22] , has been used as an indicator of   -secre-
tase complex assembly and trafficking. Within nicastrin’s 
ec todomain, a   200-amino acid region was found which 
is predicted to adopt a fold similar to the aminopeptidase 
(AP) domain. Although this domain does not confer pep-
tidase activity  [23] , its integrity is necessary for   -secre-
tase activity  [18, 22] . We have used a generalized sequence 
profile constructed from nicastrin ectodomains of vari-
ous species to search databases for nicastrin-related se-
quences and identified a novel protein which we termed 
nicalin (nicastrin-like protein)  [24] . The sequence simi-
larity is confined to a region of 180 residues, which rough-
ly corresponds to nicastrin’s AP domain. Northern and 
Western blot analysis revealed ubiquitous expression of 
nicalin in human tissues and cell lines, albeit at varying 
levels. Examination of native, endogenous nicalin from 
HEK293 cells by Blue-Native polyacrylamid gel electro-
phoresis revealed its presence in a high-molecular-weight 
membrane protein complex of   200 kDa [Haffner and 
Haass, unpubl. data], a size clearly differing from the 
500–550 kDa determined for   -secretase  [20] . Moreover, 
  -secretase components were not detected in nicalin im-
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 Fig. 2.  a Co-expression of  ncl1 and  nomo 
in zebrafish embryos results in cyclopia. 
Morphology of a wild-type embryo (left 
panel) and an embryo co-injected with 
 ncl1 and  nomo capped RNAs (right panel) 
36 h after fertilization. Note the prominent 
cyclopia of the injected embryo (arrow).
 b Roles of nicalin and nicastrin in the 
Nodal (left panel) and Notch (right panel) 
signaling pathways, respectively. The 
Nodal signal is transmitted by kinase re-
ceptors which phosphorylate intracellular 
signal transducers of the Smad family 
leading to the formation and nuclear trans-
location of heteromeric Smad complexes. 
In the nucleus, these complexes associate 
with cofactors to activate the transcription 
of target genes. The nicalin/NOMO com-
plex localizes to the endoplasmic reticu-
lum (ER) membrane and antagonizes the 
Nodal pathway at an undefined step. The 
Notch receptor is activated by ligands of 
the Delta/Serrate/LAG-2 (DSL) family and 
undergoes two proteolytic cleavage events. 
The second cleavage is mediated by   -
secretase, a membrane protein complex 
consisting of at least four components in-
cluding nicastrin. The generated Notch in-
tracellular domain (NICD) translocates to 
the nucleus and, together with cofactors, 
regulates the transcription of target genes. 
NEXT = Notch extracellular truncation; 
APH-1 = anterior pharynx defective-1; 
PEN-2 = presenilin enhancer-2. 
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munoprecipitates and vice versa, demonstrating that 
these complexes are unrelated. Immunoaffinity purifica-
tion of nicalin resulted in the co-purification of a 130-
kDa protein, which was identified by mass spectrometry 
as pM5  [24] , a membrane protein of unknown function. 
Based on the results of our analysis in zebrafish embryos 
(see below) this protein was termed NOMO (Nodal mod-
ulator). Like nicalin, NOMO is highly conserved in high-
er eukaryotes and expressed ubiquitously. Native, endog-
enous NOMO has a molecular weight of   200 kDa 
strongly suggesting its presence in the Nicalin complex. 
Glycosylation and subcellular localization studies re-
vealed that both proteins have type I topology and local-
ize to the endoplasmic reticulum [Haffner and Haass, un-
publ. data]. 
 To identify the biological function of this novel pro-
tein complex, we examined the role of nicalin and NOMO 
in the zebrafish. One NOMO  (nomo) and two nicalin or-
thologs  (ncl1, ncl2) were found in the zebrafish genome, 
of which  nomo  and ncl1 are expressed during early devel-
opment. Interfering with their expression levels in em-
bryos failed to produce phenotypes related to Notch sig-
naling deficiencies, indicating distinct functions of   -
secretase and the nicalin/NOMO complex in vivo  [24] . In 
contrast, we found that simultaneous ectopic expression 
of  nomo and  ncl1 , but not of each factor alone, led to cyc-
lopic, ‘squint-eyed’ embryos ( fig. 2 a). Blocking expres-
sion of  nomo with an antisense oligonucleotide resulted 
in the development of a massively enlarged hatching 
gland. Both phenotypes can arise through a failure in the 
proper patterning of embryonic mesendodermal tissue, a 
process regulated by the TGF  factor Nodal  [25] . In situ 
hybridization experiments demonstrated that downreg-
ulation of  nomo reduced the amount of posterior axial 
mesendoderm, indicating enhanced Nodal signaling. 
These data suggested an antagonistic role of NOMO in 
the Nodal pathway, and were confirmed by the finding 
that enhanced inhibition of Nodal signaling by overex-
pressing the specific Nodal inhibitor  lefty was counter-
acted by blocking  nomo expression  [24] . We therefore 
concluded that the nicalin/NOMO complex acts as in-
hibitor of the Nodal signaling pathway.
 Concluding Remarks 
 We characterized three novel   -secretase-related pro-
teins, SPPL2b, SPPL3 and nicalin. SPPL2b and SPPL3 are 
members of the GxGD family of aspartyl proteases and 
our data strongly support the hypothesis that they are ac-
tive proteases  [15] . This is confirmed by very recent re-
sults from our lab identifying a substrate for SPPL2b 
[Fluhrer et al., in press]. Moreover, it appears that SPPL2b 
and SPPL3 fulfill nonredundant functions important for 
vertebrate development. The characterization of sub-
strates for SPPLs and their mode of action will provide 
important insights into the mechanisms underlying the 
process of intramembrane proteolysis.
 Our analysis of the nicastrin-like protein nicalin and 
its binding partner NOMO led to the identification of a 
novel membrane protein complex involved in the Nodal 
signaling pathway  [24] . Thus, nicalin as well as nicastrin 
are both part of high-molecular-weight protein complex-
es which are involved in signaling pathways control-
ling cell fate decisions during embryonic development 
( fig. 2 b). Very recently, it has been suggested that nicas-
trin functions as a receptor for   -secretase substrates and 
that its AP domain is involved in this process by recog-
nizing the N-termini of processed peptides  [26] . Future 
studies of nicalin and NOMO might help to understand 
the precise role of nicastrin within the   -secretase com-
plex.
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